These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18677899)

  • 1. [Recent advances in molecular pathogenesis and treatment of polycystic kidney disease].
    Covic M; Covic M
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(1):11-20. PubMed ID: 18677899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recent advances in molecular pathogenesis and polycystic kidney disease treatment].
    Covic M; Covic M
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(1):13-22. PubMed ID: 21495291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTOR signaling in polycystic kidney disease.
    Ibraghimov-Beskrovnaya O; Natoli TA
    Trends Mol Med; 2011 Nov; 17(11):625-33. PubMed ID: 21775207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic kidney disease: new understanding in the pathogenesis.
    Wilson PD
    Int J Biochem Cell Biol; 2004 Oct; 36(10):1868-73. PubMed ID: 15203099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular pathophysiology of cystic kidney disease: insight into future therapies.
    Avner ED; Woychik RP; Dell KM; Sweeney WE
    Int J Dev Biol; 1999; 43(5):457-61. PubMed ID: 10535324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic advances in the treatment of polycystic kidney disease.
    Riella C; Czarnecki PG; Steinman TI
    Nephron Clin Pract; 2014; 128(3-4):297-302. PubMed ID: 25573484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD).
    Sweeney WE; Avner ED
    Cell Tissue Res; 2006 Dec; 326(3):671-85. PubMed ID: 16767405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycystic kidney disease and the renal cilium.
    Deane JA; Ricardo SD
    Nephrology (Carlton); 2007 Dec; 12(6):559-64. PubMed ID: 17995581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mouse model for polycystic kidney disease through a somatic in-frame deletion in the 5' end of Pkd1.
    Starremans PG; Li X; Finnerty PE; Guo L; Takakura A; Neilson EG; Zhou J
    Kidney Int; 2008 Jun; 73(12):1394-405. PubMed ID: 18385665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine models of polycystic kidney disease: molecular and therapeutic insights.
    Guay-Woodford LM
    Am J Physiol Renal Physiol; 2003 Dec; 285(6):F1034-49. PubMed ID: 14600027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic kidney diseases: from molecular discoveries to targeted therapeutic strategies.
    Ibraghimov-Beskrovnaya O; Bukanov N
    Cell Mol Life Sci; 2008 Feb; 65(4):605-19. PubMed ID: 17975706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pkd1 and Nek8 mutations affect cell-cell adhesion and cilia in cysts formed in kidney organ cultures.
    Natoli TA; Gareski TC; Dackowski WR; Smith L; Bukanov NO; Russo RJ; Husson H; Matthews D; Piepenhagen P; Ibraghimov-Beskrovnaya O
    Am J Physiol Renal Physiol; 2008 Jan; 294(1):F73-83. PubMed ID: 17928412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic liver and kidney diseases.
    Tahvanainen E; Tahvanainen P; Kääriäinen H; Höckerstedt K
    Ann Med; 2005; 37(8):546-55. PubMed ID: 16338757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autosomal dominant polycystic kidney disease: molecular genetics and pathophysiology.
    Sutters M; Germino GG
    J Lab Clin Med; 2003 Feb; 141(2):91-101. PubMed ID: 12577044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro cystogenesis: the search for drugs antagonizing cyst development.
    Ibraghimov-Beskrovnaya O; Bukanov NO
    Nephrol Ther; 2006 Jan; 2 Suppl 2():S109-14. PubMed ID: 17373209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genetic screen in zebrafish identifies cilia genes as a principal cause of cystic kidney.
    Sun Z; Amsterdam A; Pazour GJ; Cole DG; Miller MS; Hopkins N
    Development; 2004 Aug; 131(16):4085-93. PubMed ID: 15269167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of polycystic kidney disease in juvenile cystic kidney mice: insights into pathogenesis, ciliary abnormalities, and common features with human disease.
    Smith LA; Bukanov NO; Husson H; Russo RJ; Barry TC; Taylor AL; Beier DR; Ibraghimov-Beskrovnaya O
    J Am Soc Nephrol; 2006 Oct; 17(10):2821-31. PubMed ID: 16928806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetics of polycystic kidney disease.
    Calvet JP
    J Nephrol; 1998; 11(1):24-34. PubMed ID: 9561482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathogenesis of polycystic kidney disease.
    Carone FA; Bacallao R; Kanwar YS
    Histol Histopathol; 1995 Jan; 10(1):213-21. PubMed ID: 7756739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat.
    Wang X; Gattone V; Harris PC; Torres VE
    J Am Soc Nephrol; 2005 Apr; 16(4):846-51. PubMed ID: 15728778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.